Literature DB >> 28695375

Rigor of non-dairy galactose restriction in early childhood, measured by retrospective survey, does not associate with severity of five long-term outcomes quantified in 231 children and adults with classic galactosemia.

Allison B Frederick1, David J Cutler1, Judith L Fridovich-Keil2.   

Abstract

One of many vexing decisions faced by parents of an infant with classic galactosemia (CG) is how carefully to restrict non-dairy galactose from their growing child's diet. Until recently, many experts recommended vigorous lifelong dietary restriction of milk and all high-galactose dairy products as well as some non-dairy sources of galactose such as legumes and specific fruits and vegetables. Recently, experts have begun to relax their recommendations. The new recommendations, that restrict only high galactose dairy products, were made in the face of uncertainty, however, because no sufficiently powered study had been reported testing for possible association between rigor of non-dairy galactose restriction and severity of long-term outcomes in CG. Here we describe the largest study of diet and outcomes in CG reported to date, conducted using information gathered from 231 patients with CG and 71 unaffected sibling controls. We compared rigor of dietary galactose restriction, measured using a 4-point scale by a retrospective parent-response survey, with outcomes including growth, adaptive behaviors, receipt of speech therapy, receipt of special educational services, and for girls and women, a plasma marker of ovarian function (AMH). Our results confirmed the expected differences between patients and controls, but among patients showed no significant association between rigor of non-dairy galactose restriction in early childhood and any of the outcomes quantified. Indeed, some weak associations were seen suggesting that rigorous restriction of non-dairy galactose may be deleterious rather than beneficial. Despite limitations, these findings support the ongoing trend toward diet liberalization with regard to non-dairy sources of galactose for children and adults with classic galactosemia.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28695375      PMCID: PMC5656392          DOI: 10.1007/s10545-017-0067-x

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  23 in total

1.  High tolerance for oral galactose in classical galactosaemia: dietary implications.

Authors:  A M Bosch; H D Bakker; L J M de B Wenniger-Prick; R J A Wanders; F A Wijburg
Journal:  Arch Dis Child       Date:  2004-11       Impact factor: 3.791

2.  Untreated classical galactosemia patient with mild phenotype.

Authors:  Bianca Panis; Jaap A Bakker; Jean-Pierre J E Sels; Leo J M Spaapen; Luc J C van Loon; M Estela Rubio-Gozalbo
Journal:  Mol Genet Metab       Date:  2006-04-18       Impact factor: 4.797

Review 3.  A re-evaluation of life-long severe galactose restriction for the nutrition management of classic galactosemia.

Authors:  Sandra C Van Calcar; Laurie E Bernstein; Frances J Rohr; Christine H Scaman; Steven Yannicelli; Gerard T Berry
Journal:  Mol Genet Metab       Date:  2014-05-02       Impact factor: 4.797

4.  Endogenous galactose formation in galactose-1-phosphate uridyltransferase deficiency.

Authors:  Peter Schadewaldt; Loganathan Kamalanathan; Hans-Werner Hammen; Jorg Kotzka; Udo Wendel
Journal:  Arch Physiol Biochem       Date:  2014-09-30       Impact factor: 4.076

5.  Parent recruitment and retention in a universal prevention program for child behavior and emotional problems: barriers to research and program participation.

Authors:  Nina Heinrichs; Heike Bertram; Annett Kuschel; Kurt Hahlweg
Journal:  Prev Sci       Date:  2005-12

6.  Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.

Authors:  Emily L Ryan; Mary Ellen Lynch; Elles Taddeo; Tyler J Gleason; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2013-01-15       Impact factor: 4.982

7.  Biomarkers of ovarian function in girls and women with classic galactosemia.

Authors:  Rebecca D Sanders; Jessica B Spencer; Michael P Epstein; Susan V Pollak; Pratibhasri A Vardhana; Joyce W Lustbader; Judith L Fridovich-Keil
Journal:  Fertil Steril       Date:  2008-08-05       Impact factor: 7.329

8.  Effects of temporary low-dose galactose supplements in children aged 5-12 y with classical galactosemia: a pilot study.

Authors:  Ina Knerr; Karen Patricia Coss; Jürgen Kratzsch; Ellen Crushell; Anne Clark; Peter Doran; Yoon Shin; Henning Stöckmann; Pauline Mary Rudd; Eileen Treacy
Journal:  Pediatr Res       Date:  2015-06-08       Impact factor: 3.756

9.  Modifiers of ovarian function in girls and women with classic galactosemia.

Authors:  Jessica B Spencer; Jennifer R Badik; Emily L Ryan; Tyler J Gleason; K Alaine Broadaway; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Clin Endocrinol Metab       Date:  2013-05-20       Impact factor: 5.958

Review 10.  International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up.

Authors:  Lindsey Welling; Laurie E Bernstein; Gerard T Berry; Alberto B Burlina; François Eyskens; Matthias Gautschi; Stephanie Grünewald; Cynthia S Gubbels; Ina Knerr; Philippe Labrune; Johanna H van der Lee; Anita MacDonald; Elaine Murphy; Pat A Portnoi; Katrin Õunap; Nancy L Potter; M Estela Rubio-Gozalbo; Jessica B Spencer; Inge Timmers; Eileen P Treacy; Sandra C Van Calcar; Susan E Waisbren; Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2016-11-17       Impact factor: 4.982

View more
  7 in total

1.  Biochemical changes and clinical outcomes in 34 patients with classic galactosemia.

Authors:  Tatiana Yuzyuk; Krista Viau; Ashley Andrews; Marzia Pasquali; Nicola Longo
Journal:  J Inherit Metab Dis       Date:  2018-01-19       Impact factor: 4.982

2.  Presentation, progression, and predictors of ovarian insufficiency in classic galactosemia.

Authors:  Allison B Frederick; Alison M Zinsli; Grace Carlock; Karen Conneely; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2018-05-02       Impact factor: 4.982

3.  A galactose-1-phosphate uridylyltransferase-null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue-specific and longitudinal differences in galactose metabolism.

Authors:  Shauna A Rasmussen; Jennifer M I Daenzer; Jessica A MacWilliams; S Taylor Head; Martine B Williams; Aron M Geurts; Jason P Schroeder; David Weinshenker; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2019-12-29       Impact factor: 4.982

4.  Fertility in classical galactosaemia, a study of N-glycan, hormonal and inflammatory gene interactions.

Authors:  Hugh-Owen Colhoun; Estela M Rubio Gozalbo; Annet M Bosch; Ina Knerr; Charlotte Dawson; Jennifer Brady; Marie Galligan; Karolina Stepien; Roisin O'Flaherty; C Catherine Moss; P Peter Barker; Maria Fitzgibbon; Peter P Doran; Eileen P Treacy
Journal:  Orphanet J Rare Dis       Date:  2018-09-19       Impact factor: 4.123

5.  The natural history of classic galactosemia: lessons from the GalNet registry.

Authors:  M E Rubio-Gozalbo; M Haskovic; A M Bosch; B Burnyte; A I Coelho; D Cassiman; M L Couce; C Dawson; D Demirbas; T Derks; F Eyskens; M T Forga; S Grunewald; J Häberle; M Hochuli; A Hubert; H H Huidekoper; P Janeiro; J Kotzka; I Knerr; P Labrune; Y E Landau; J G Langendonk; D Möslinger; D Müller-Wieland; E Murphy; K Õunap; D Ramadza; I A Rivera; S Scholl-Buergi; K M Stepien; A Thijs; C Tran; R Vara; G Visser; R Vos; M de Vries; S E Waisbren; M M Welsink-Karssies; S B Wortmann; M Gautschi; E P Treacy; G T Berry
Journal:  Orphanet J Rare Dis       Date:  2019-04-27       Impact factor: 4.123

6.  Abnormal N-glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake.

Authors:  Eileen P Treacy; Sebastian Vencken; Annet M Bosch; Matthias Gautschi; Estela Rubio-Gozalbo; Charlotte Dawson; Darragh Nerney; Hugh Owen Colhoun; Loai Shakerdi; Gregory M Pastores; Roisin O'Flaherty; Radka Saldova
Journal:  JIMD Rep       Date:  2021-07-22

7.  Hand fine motor control in classic galactosemia.

Authors:  Jessica MacWilliams; Sneh Patel; Grace Carlock; Sarah Vest; Nancy L Potter; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2021-03-23       Impact factor: 4.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.